Dermata Therapeutics, Inc.
DRMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001853816
No open-market purchases or sales by Dermata Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $158.0K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Dermata Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 45.5K | 518.5K | +473.0K (+1,038.9%) |
| Value | $61.5K | $561.2K | +$499.7K (+813.0%) |
New holders (2)
Institutions that held Dermata Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 20,406 | $22.0K | 0.00% |
| Jones Financial Companies LLLP | 12,000 | $14.2K | 0.00% |
Sold out (0)
Institutions that held Dermata Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.